Search Within

GSK Faculty

Formats
  1. Journal Article (13960)
  2. Meeting Abstract (7136)
  3. Review (530)
  4. Book Section (346)
  5. Editorial (315)
  6. Conference Paper (163)
  7. Research Letter (96)
  8. Miscellaneous (46)
  9. Correspondence (38)
  10. Guidelines (33)
  11. Book Whole (24)
Groups
  1. Sloan Kettering Institute Faculty (11554)
  2. Department of Medicine (10642)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (8374)
  4. Tow Center for Developmental Oncology (TCDO) (7024)
  5. Sloan Kettering Institute Postdocs (6329)
  6. Solid Tumor Oncology Division (5941)

More Groups

People
  1. Marc Ladanyi (1335)
  2. Steven Larson (960)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (904)
  5. Kenneth Offit (792)
  6. Ross Levine (787)

More People

Years
  1. 2025 (485)
  2. 2024 (904)
  3. 2023 (1015)
  4. 2022 (1148)
  5. 2021 (1087)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1506)
  2. Journal of Clinical Oncology (1295)
  3. Cancer Research (1105)
  4. Clinical Cancer Research (531)
  5. Modern Pathology (497)
  6. Journal of Nuclear Medicine (476)

More Publications

Publishers
  1. Nature Publishing Group (2630)
  2. American Association for Cancer Research (2205)
  3. Elsevier Inc. (1882)
  4. American Society of Hematology (1590)
  5. Cell Press (1442)
  6. American Society of Clinical Oncology (1398)

More Publishers

Results (22687)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correction of small bias for clinically relevant CpG sites interrogated by the updated EPICv2/900K methylation array
    Meeting Abstract

    Aldyab, M.; Upadhyayula, N.; Borsu, L.; Nafa, K.; Villafania, L.; Zaidinski, M.; Mullhaney, K.; Bale, T.; Arcila, M.; Ladanyi, M.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Receptor tyrosine kinase inhibition results in the regression of acral melanoma by targeting the tumor microenvironment
    Meeting Abstract

    Smith, E. A.; Belote, R. L.; Cruz, N. E.; Mustafa, T. E.; Becker, C.; Alizada, S.; Chan, T.; Seasor, T. A.; Balatico, M.; Cortes-Sanchez, E.; more...
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Critical roles of type I interferon receptor signaling in myeloid and T cells for virus-induced antitumor responses
    Meeting Abstract

    Baseer Tariq, S.; Wang, Y.; Wang, W.; Salla, B.; Wang, Y.; Liu, S.; Yang, N.; Li, M.; Deng, L.
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    De Groot, J. F.; Cloughesy, T. F.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and genomic analysis of HER2-mutant, metastatic triple-negative breast cancer treated with neratinib alone or in combination with trastuzumab in the phase 2 SUMMIT basket trial
    Meeting Abstract

    Jhaveri, K. L.; Hurvitz, S. A.; Brufsky, A.; Bose, R.; de Miguel, M. J.; Evron, E.; Unni, N.; Reid, S. A.; Quinn, D. I.; Mahalingam, D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 study of NB003, a broad-spectrum KIT/PDGFRα inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Li, J.; Chi, P.; Kang, Y. K.; Cao, H.; George, S.; Zhang, J.; Zhang, J.; Hu, K.; Zhang, L. J.; Xu, Y. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • DCC-3116 in combination with ripretinib for patients with advanced gastrointestinal stromal tumor: A phase 1/2 study
    Meeting Abstract

    Chandana, S. R.; Shepard, D. R.; Mehnert, J. M.; Chi, P.; Trent, J. C.; Psoinos, C. M.; Zhou, B.; Black, V.; Viswanathan, L.; Gozo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • IDeate-Lung02: A phase 3, randomized, open-label study of ifinatamab deruxtecan (I-DXd) vs treatment of physician's choice (TPC) in relapsed small cell lung cancer (SCLC)
    Meeting Abstract

    Owonikoko, T. K.; Byers, L. A.; Cheng, Y.; Hayashi, H.; Paz-Ares, L. G.; Perol, M.; Turner, J.; Qian, M.; Garcia, C. R.; Godard, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Yuen, K. L.; Gomez, J.; Castano, N.; Ajmera, A.; Ye, H.; Pili, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multidimensional analysis of B7 homolog 3 (B7-H3) RNA expression in small-cell lung cancer (SCLC) molecular subtypes
    Meeting Abstract

    Gay, C. M.; Owonikoko, T. K.; Byers, L. A.; Choudhury, N. J.; Ahmed, S.; Cain, Z.; Qian, X. Z.; Brentnall, M.; Heeke, S.; Poi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save